Do different beta-blockers vary in efficacy in reducing the risk of cardiac events in long QT syndrome (LQTS) and in genotype-positive LQT1 and LQT2 patients?
Source: www.cardiosource.org
October 24, 2014 by 2012pharmaceutical
Do different beta-blockers vary in efficacy in reducing the risk of cardiac events in long QT syndrome (LQTS) and in genotype-positive LQT1 and LQT2 patients?
Source: www.cardiosource.org
Leave a Reply